QA: Sio Gene Therapies Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2017_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 282,086,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 89,000
3 remainder_Assets 323,000
4 LiabilitiesCurrent 15,755,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 56,518,000
9 ResearchAndDevelopmentExpense 76,600,000
10 remainder_Expenses 27,000
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 282,498,000
1 Liabilities 15,755,000
2 Expenses 133,145,000
3 Revenues 0
4 StockholdersEquity 266,743,000
5 NetIncome -133,145,000
6 ComprehensiveNetIncome -133,145,000
7 BaseVar 215,699,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.01
9 EconomicCapitalRatio 3.69

Edgar->Model Mapping

Feature Distribution